Skip to main content

Peer Review reports

From: Drug cost avoidance analysis of cancer clinical trials in Spain: a study on cost contributors and their impact

Original Submission
23 Jan 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
25 Mar 2022 Reviewed Reviewer Report
4 Apr 2022 Reviewed Reviewer Report
18 Apr 2022 Author responded Author comments - Salas-Lucia Federico
Resubmission - Version 3
18 Apr 2022 Submitted Manuscript version 3
9 May 2022 Reviewed Reviewer Report
21 May 2022 Author responded Author comments - Salas-Lucia Federico
Resubmission - Version 4
21 May 2022 Submitted Manuscript version 4
6 Jun 2022 Author responded Author comments - Salas-Lucia Federico
Resubmission - Version 5
6 Jun 2022 Submitted Manuscript version 5
7 Jun 2022 Author responded Author comments - Salas-Lucia Federico
Resubmission - Version 6
7 Jun 2022 Submitted Manuscript version 6
Publishing
13 Jun 2022 Editorially accepted
26 Jul 2022 Article published 10.1186/s12913-022-08222-9

You can find further information about peer review here.

Back to article page